Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bristol-Myers Earnings Preview
Yahoo/Zacks.com
Thursday, April 21, 2011 - 6:48pm
tags:
Bristol-Myers Squibb, earnings
Report: GSK mulls deal for India vaccines unit
Fierce Pharma
Thursday, April 21, 2011 - 11:49am
tags:
vaccines, GSK, M&A, Biological E, India
Incyte and YM Biosciences in Race to Market Strongest JAK Inhibitor
Seeking Alpha
Thursday, April 21, 2011 - 11:46am
tags:
JAK inhibitors, YM BioSciences, Incyte, myelofibrosis
AEterna Zentaris Looks Ready to Make New Highs
Seeking Alpha
Thursday, April 21, 2011 - 11:01am
tags:
Aeterna Zentaris, perifosine
Amgen says it will pay dividend starting in 2Q
Yahoo/AP
Thursday, April 21, 2011 - 10:56am
tags:
dividends, Amgen
How Do These Pharmas Really Boost Their Returns?
Motley Fool
Thursday, April 21, 2011 - 10:56am
tags:
Merck, Pfizer, Abbott Laboratories, GSK, ROE
Should You Sell Abbott Labs Today?
Motley Fool
Thursday, April 21, 2011 - 10:37am
tags:
Abbott Laboratories
Titan Should Be on the Biotech Watch Lists Right Now
Seeking Alpha
Thursday, April 21, 2011 - 9:54am
tags:
Titan, Novartis, Fanapt
Biogen revenue, profit up in Q1
Bizjournals.com
Thursday, April 21, 2011 - 9:50am
tags:
Biogen Idec, earnings
Depomed: Light-Risk Small Pharma With Huge Potential
Seeking Alpha
Thursday, April 21, 2011 - 9:49am
tags:
Depomed
New generics quickly grab 80% of sales volume
Fierce Pharma
Thursday, April 21, 2011 - 9:25am
tags:
prescription data, generics
Roche's Genentech Sues Novartis Unit Claiming Infringement of Valcyte Drug
Bloomberg
Thursday, April 21, 2011 - 9:23am
tags:
Genentech, Novartis, Valcyte, generics, patents, AIDS
Merck, Vertex Prep for Hep C Drug Panels
TheStreet.com
Thursday, April 21, 2011 - 9:21am
tags:
Merck, Vertex Pharmaceuticals, hepatitis C, FDA, Boceprevir, Telaprevir, advisory panels
Pfizer, Shanghai Pharma Agree to Explore China Cooperation
Bloomberg
Thursday, April 21, 2011 - 9:19am
tags:
Pfizer, China, Shanghai Pharmaceutical
Gilead Q1 profit dips to $651.1M
Bizjournals.com
Wednesday, April 20, 2011 - 7:07pm
tags:
earnings, Gilead Sciences
Amgen Beats on Top and Bottom Lines, but Shares Drop
Bizjournals.com
Wednesday, April 20, 2011 - 7:00pm
tags:
Amgen, earnings
Dynavax gets $6M for start of human tests of lupus treatment
Bizjournals.com
Wednesday, April 20, 2011 - 6:55pm
tags:
lupus, GSK, Dynavax, DV1179
Turnaround at Johnson & Johnson? Let's Do Some Math.
Motley Fool
Wednesday, April 20, 2011 - 6:54pm
tags:
JNJ
CROs scramble as Big Pharma lines up strategic partnerships
Fierce Biotech
Wednesday, April 20, 2011 - 12:20pm
tags:
CROs, Big Pharma, R&D, Covance, PPD, Parexel, Charles River Laboratories, ICON, Kendle, Quintiles
J&J defends executive pay to institutional investors
Fierce Pharma
Wednesday, April 20, 2011 - 12:07pm
tags:
JNJ, executive pay

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.